,outcome,arm 1,arm 2
0,intervention,,
0,"Protocol-defined cardiotoxicity, total study group","13 % of TLC D-99 patients, 2 cases, 29 % of doxorubicin patients, 9 cases","13 % of TLC D-99 patients, 2 cases, 29 % of doxorubicin patients, 9 cases"
